EUVIMEDDescoperă EUVIMED
Crossref

Isoliquiritigenin Exhibits Anti‐Inflammatory Responses in Acute Lung Injury by Covalently Binding to the Myeloid Differentiation Protein‐2 Domain

Liu Yang iD, Haoran Nie, Yan Du, Xuyang Liu, Bangrong Cai, Jiansheng Li iD

Phytotherapy Research · 2025

DOI: 10.1002/ptr.8411 ↗

At a glance

Journal article in Phytotherapy Research, 2025. Written by Liu Yang and 5 co-authors. Institution: Co-Construction Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases by Henan and Education Ministry of P.R. China, Academy …. Major MEDLINE topics: Acute Lung Injury, Chalcones, Lymphocyte Antigen 96, Anti-Inflammatory Agents. Cited 4 times so far (Crossref); 63 references. Funded by: China Postdoctoral Science Foundation, National Natural Science Foundation of China, Key Scientific Research Project Plan of Colleges and Universities in Henan Province.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Acute lung injury (ALI), a systemic inflammatory response with high morbidity, lacks effective pharmacological therapies. Myeloid differentiation protein‐2 (MD2) has emerged as a promising therapeutic target for ALI. Herein, we aimed to evaluate the ability of isoliquiritigenin (ISL), a natural flavonoid found in licorice as a novel MD2 inhibitor, to inhibit lipopolysaccharide (LPS)‐induced ALI. We established a mouse ALI model and a RAW 264.7 cell injury model through LPS administration. Then, lung injury was assessed through histopathological examination, and the effects of ISL were evaluated using immunofluorescence, western blotting, reverse transcription–quantitative polymerase chain reaction, flow cytometry, and enzyme‐linked immunosorbent assays. In addition, the interaction between ISL and MD2 was investigated through co‐immunoprecipitation and LPS displacement assays. Molecular docking and liquid chromatography/mass spectrometry analyses were employed to predict the ISL‐binding domain of MD2. We found that ISL covalently bound to the Cysteine 133 residue of MD2, disrupting the formation of the LPS/MD2/toll‐like receptor 4 complex, and ISL significantly suppressed proinflammatory cytokine production and reactive oxygen species generation in LPS‐induced RAW264.7 cells. Moreover, ISL significantly alleviated lung injury in LPS‐induced mice, reducing pulmonary microvascular permeability, inflammatory cell infiltration, and inflammatory cytokine expression. The underlying mechanism of ISL involved the inhibition of nuclear factor kappa B and the p38 mitogen‐activated protein kinase pathway. Our findings supported that MD2 is the direct target of ISL in mediating its anti‐inflammatory response in vivo and in vitro, and it holds potential as a therapeutic candidate for treating ALI and other inflammatory diseases.

Subjects

MeSH terms (MEDLINE)

Acute Lung InjuryChalconesLymphocyte Antigen 96Anti-Inflammatory AgentsAnimalsMiceRAW 264.7 CellsLipopolysaccharidesMolecular Docking SimulationMaleCytokinesReactive Oxygen SpeciesDisease Models, AnimalMice, Inbred C57BLLungToll-Like Receptor 4NF-kappa B

Author keywords

NF‐κB signalingTLR4/MD2 complexacute lung injuryisoliquiritigeninmyeloid differentiation protein‐2

Substances

ChalconesisoliquiritigeninLymphocyte Antigen 96LipopolysaccharidesAnti-Inflammatory AgentsLy96 protein, mouseCytokinesReactive Oxygen SpeciesToll-Like Receptor 4NF-kappa B

Authors and institutions

  • Co-Construction Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases by Henan and Education Ministry of P.R. China, Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhe…
  • Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Henan University of Chinese Medicine, Zhengzhou, Henan Province, China.
  • Henan Research Center for Special Processing Technology of Chinese Medicine, School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, China.
  • Department of Respiratory Diseases, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.

ORCID profiles: Liu Yang, Jiansheng Li

Funding

  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China
  • Key Scientific Research Project Plan of Colleges and Universities in Henan Province

Cite

APA

Yang, L., Nie, H., Du, Y., Liu, X., Cai, B., & Li, J. (2025). Isoliquiritigenin Exhibits Anti‐Inflammatory Responses in Acute Lung Injury by Covalently Binding to the Myeloid Differentiation Protein‐2 Domain. Phytotherapy Research. https://doi.org/10.1002/ptr.8411

Vancouver

Yang L, Nie H, Du Y, Liu X, Cai B, Li J. Isoliquiritigenin Exhibits Anti‐Inflammatory Responses in Acute Lung Injury by Covalently Binding to the Myeloid Differentiation Protein‐2 Domain. Phytotherapy Research. 2025. doi:10.1002/ptr.8411

BibTeX
@article{Yang2025,
  author = {Yang, Liu and Nie, Haoran and Du, Yan and Liu, Xuyang and Cai, Bangrong and Li, Jiansheng},
  title = {Isoliquiritigenin Exhibits Anti‐Inflammatory Responses in Acute Lung Injury by Covalently Binding to the Myeloid Differentiation Protein‐2 Domain},
  journal = {Phytotherapy Research},
  year = {2025},
  doi = {10.1002/ptr.8411}
}
Start for free →